Syros医药 (SYRS)公告，Syros医药新闻

公告

0.00%

全部
财务报告
内部人交易

10-K Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-03-04 06:55
S-8 Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-03-04 07:17
8-K Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-02-25 07:01
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2021-02-19 16:10
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2021-02-19 16:12
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2021-02-19 16:13
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2021-02-19 16:14
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2021-02-19 16:15
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2021-02-19 16:16
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2021-02-18 17:34
SC 13G/A Syros Pharmaceuticals, Inc. (0001556263) (Subject)
2021-02-16 16:33
SC 13G/A Syros Pharmaceuticals, Inc. (0001556263) (Subject)
2021-02-16 15:12
SC 13G/A Syros Pharmaceuticals, Inc. (0001556263) (Subject)
2021-02-11 17:27
4/A Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2021-02-10 17:28
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2021-02-10 17:29
SC 13G/A Syros Pharmaceuticals, Inc. (0001556263) (Subject)
2021-02-05 06:10
CT ORDER Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-02-03 13:39
SC 13G/A Syros Pharmaceuticals, Inc. (0001556263) (Subject)
2021-02-02 17:02
424B3 Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-01-27 08:41
424B5 Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-01-20 16:02
8-K Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-01-20 16:04
EFFECT Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-01-20 00:16
424B5 Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-01-19 16:06
8-K Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-01-19 16:00
8-K Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2021-01-11 07:53
8-K Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2020-12-23 16:07
4 Syros Pharmaceuticals, Inc.
2020-12-21 16:58
4/A Syros Pharmaceuticals, Inc.
2020-12-21 17:01
SC 13G Syros Pharmaceuticals, Inc.
2020-12-14 17:12
4 Syros Pharmaceuticals, Inc.
2020-12-11 20:52
8-K Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2020-12-07 06:05
Form4 Syros Pharmaceuticals, Inc.
2020-11-18 16:33
10-Q Syros Pharmaceuticals, Inc.
2020-11-05 15:30
Form8-K Syros Pharmaceuticals, Inc.
2020-10-26 06:10
Form4 Syros Pharmaceuticals, Inc.
2020-10-19 18:36
Form4 Syros Pharmaceuticals, Inc.
2020-10-16 16:39
FormSC 13G/A Syros Pharmaceuticals, Inc.
2020-10-09 14:16
Form4 Syros Pharmaceuticals, Inc.
2020-09-16 08:32
Form4 Syros Pharmaceuticals, Inc.
2020-09-09 08:51
3 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2020-09-09 08:49
8-K Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2020-09-09 08:30
Form4 Syros Pharmaceuticals, Inc.
2020-08-19 16:33
Form4 Syros Pharmaceuticals, Inc.
2020-08-19 16:35
Form4 Syros Pharmaceuticals, Inc.
2020-08-19 16:03
Form10-Q Syros Pharmaceuticals, Inc.
2020-08-06 07:01
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2020-07-17 16:11
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2020-07-07 19:33
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2020-07-06 16:00
4 Syros Pharmaceuticals, Inc. (0001556263) (Issuer)
2020-06-25 20:38
424B5 Syros Pharmaceuticals, Inc. (0001556263) (Filer)
2020-06-23 17:16

微牛提供最新的Syros医药(SYRS)股票新闻与公司公告，以帮助你进行明智的交易与投资决策。

SYRS 简况

Syros Pharmaceuticals Inc是一家生物制药公司。该公司致力于重新定义小分子控制基因表达的能力。它专注于开发由单一基因突变（单基因疾病）导致的癌症和疾病的治疗方法，并建立基因控制药物的渠道。它的候选产品包括SY-1425、SY-5609和SY-2101。SY-1425是一种选择性维甲酸受体α（RAR）激动剂，正在与氮胞苷联合评估，以用于治疗急性髓细胞性白血病（AML）。SY-5609是选择性和有效的细胞周期蛋白依赖性激酶7（CDK7）口服抑制剂，正在针对部分晚期实体瘤患者进行剂量递增部分评估。SY-2101是正在开发的用于治疗AML的口服三氧化二砷（ATO）。